Treatment of cultured multiple myeloma cells with MLN8237, which is a small-molecule, and Aurora-A kinase inhibitor that inhibits Aurora-A gene expression by siRNA, results in G2/M arrest and senescence in vitro28. This evidence concerns the gene AURKA and plasma cell myeloma.